Cargando…
TB or not to be: what specificities and impact do antibodies have during tuberculosis?
Tuberculosis, an infectious disease caused by Mycobacterium tuberculosis (Mtb), is a major cause of global morbidity and mortality. The primary barrier to the development of an effective tuberculosis vaccine is our failure to fully understand the fundamental characteristics of a protective immune re...
Autores principales: | Hermann, Clemens, King, Carolyn G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914581/ https://www.ncbi.nlm.nih.gov/pubmed/36845566 http://dx.doi.org/10.1093/oxfimm/iqab015 |
Ejemplares similares
-
What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?
por: Harries, Anthony D., et al.
Publicado: (2018) -
Do Myositis-Specific Antibodies have Specific Histopathological Marks?
por: Katirji, Bashar
Publicado: (2023) -
An Update on Global Tuberculosis (TB)
por: Talip, Balkis A., et al.
Publicado: (2013) -
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
por: Albert, Heidi, et al.
Publicado: (2016) -
Psychotherapies for PTSD: what do they have in common?
por: Schnyder, Ulrich, et al.
Publicado: (2015)